Literature DB >> 25870122

Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.

Carlos A Báez-Pagán1, Manuel Delgado-Vélez, José A Lasalde-Dominicci.   

Abstract

Inflammatory responses to stimuli are essential body defenses against foreign threats. However, uncontrolled inflammation may result in serious health problems, which can be life-threatening. The α7 nicotinic acetylcholine receptor, a ligand-gated ion channel expressed in the nervous and immune systems, has an essential role in the control of inflammation. Activation of the macrophage α7 receptor by acetylcholine, nicotine, or other agonists, selectively inhibits production of pro-inflammatory cytokines while leaving anti-inflammatory cytokines undisturbed. The neural control of this regulation pathway was discovered recently and it was named the cholinergic anti-inflammatory pathway (CAP). When afferent vagus nerve terminals are activated by cytokines or other pro-inflammatory stimuli, the message travels through the afferent vagus nerve, resulting in action potentials traveling down efferent vagus nerve fibers in a process that eventually leads to macrophage α7 activation by acetylcholine and inhibition of pro-inflammatory cytokines production. The mechanism by which activation of α7 in macrophages regulates pro-inflammatory responses is subject of intense research, and important insights have thus been made. The results suggest that activation of the macrophage α7 controls inflammation by inhibiting NF-κB nuclear translocation, and activating the JAK2/STAT3 pathway among other suggested pathways. While the α7 is well characterized as a ligand-gated ion channel in neurons, whole-cell patch clamp experiments suggest that α7's ion channel activity, defined as the translocation of ions across the membrane in response to ligands, is absent in leukocytes, and therefore, ion channel activity is generally assumed not to be required for the operation of the CAP. In this perspective, we briefly review macrophage α7 activation as it relates to the control of inflammation, and broaden the current view by providing single-channel currents as evidence that the α7 expressed in macrophages retains its ion translocation activity despite the absence of whole-cell currents. Whether this ion-translocating activity is relevant for the proper operation of the CAP or other important physiological processes remains obscure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870122      PMCID: PMC4546521          DOI: 10.1007/s11481-015-9601-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  50 in total

1.  A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

Authors:  Raymond S Hurst; Mihaly Hajós; Mario Raggenbass; Theron M Wall; Nicole R Higdon; Judy A Lawson; Karen L Rutherford-Root; Mitchell B Berkenpas; W E Hoffmann; David W Piotrowski; Vincent E Groppi; Geraldine Allaman; Roch Ogier; Sonia Bertrand; Daniel Bertrand; Stephen P Arneric
Journal:  J Neurosci       Date:  2005-04-27       Impact factor: 6.167

2.  Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway.

Authors:  Wouter J de Jonge; Esmerij P van der Zanden; Frans O The; Maarten F Bijlsma; David J van Westerloo; Roelof J Bennink; Hans-Rudolf Berthoud; Satoshi Uematsu; Shizuo Akira; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Nat Immunol       Date:  2005-07-17       Impact factor: 25.606

Review 3.  Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.

Authors:  Dimitra Kalamida; Konstantinos Poulas; Vassiliki Avramopoulou; Efrosini Fostieri; George Lagoumintzis; Konstantinos Lazaridis; Anastasia Sideri; Marios Zouridakis; Socrates J Tzartos
Journal:  FEBS J       Date:  2007-08       Impact factor: 5.542

Review 4.  Allosteric receptors after 30 years.

Authors:  J P Changeux; S J Edelstein
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

5.  Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases.

Authors:  Eric Charpantier; Andreas Wiesner; Kyung-Hye Huh; Roch Ogier; Jean-Charles Hoda; Geraldine Allaman; Mario Raggenbass; Dominik Feuerbach; Daniel Bertrand; Christian Fuhrer
Journal:  J Neurosci       Date:  2005-10-26       Impact factor: 6.167

6.  Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7.

Authors:  H Yoshikawa; M Kurokawa; N Ozaki; K Nara; K Atou; E Takada; H Kamochi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

7.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.

Authors:  Hong Wang; Hong Liao; Mahendar Ochani; Marilou Justiniani; Xinchun Lin; Lihong Yang; Yousef Al-Abed; Haichao Wang; Christine Metz; Edmund J Miller; Kevin J Tracey; Luis Ulloa
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

Review 8.  Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.

Authors:  H R Arias
Journal:  Biochim Biophys Acta       Date:  1998-08-21

9.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB.

Authors:  Jinbo Yang; Xudong Liao; Mukesh K Agarwal; Laura Barnes; Philip E Auron; George R Stark
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

10.  Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state.

Authors:  Manuel Delgado-Vélez; Ana Lugo-Chinchilla; Luis Lizardo; Irmarie Morales; Yarelis Robles; Nimaris Bruno; José W Rodríguez; Eddy Ríos-Olivares; Miguel Correa; Fernando L Renaud
Journal:  J Neuroimmunol       Date:  2008-04-08       Impact factor: 3.478

View more
  61 in total

Review 1.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

2.  Mefenamic Acid Attenuates Chronic Alcohol Induced Cognitive Impairment in Zebrafish: Possible Role of Cholinergic Pathway.

Authors:  Venugopalan Rajesh; Mohanan Mridhulmohan; Subramanian Jayaseelan; Palanivel Sivakumar; Vellaiyachamy Ganesan
Journal:  Neurochem Res       Date:  2018-05-23       Impact factor: 3.996

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 4.  Cholinergic modulation of the immune system presents new approaches for treating inflammation.

Authors:  Donald B Hoover
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

Review 5.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 6.  Molecular function of α7 nicotinic receptors as drug targets.

Authors:  Cecilia Bouzat; Matías Lasala; Beatriz Elizabeth Nielsen; Jeremías Corradi; María Del Carmen Esandi
Journal:  J Physiol       Date:  2017-11-29       Impact factor: 5.182

7.  Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness.

Authors:  Siomara Hernandez; David E Fried; Vladimir Grubišić; Jonathon L McClain; Brian D Gulbransen
Journal:  FASEB J       Date:  2019-02-21       Impact factor: 5.191

8.  Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.

Authors:  Charles N Serhan; Xavier de la Rosa; Charlotte C Jouvene
Journal:  J Immunol       Date:  2018-10-24       Impact factor: 5.422

Review 9.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

Review 10.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.